400
Participants
Start Date
March 31, 2005
Study Completion Date
May 31, 2006
XBD173
Investigational Site, Atlanta
Investigational Site, West Palm Beach
Investigational Site, St. Petersburg
Investigational Site, Fort Meyers
Investigational Site, Madison
Investigational Site, Memphis
Investigational Site, Dayton
Investigational Site, Hoffman Estates
Investigational Site, Oak Brook
Investigational Site, Overland Park
Investigational Site, Los Angeles
Investigational Site, San Diego
Investigational Site, Redlands
Investigational Site, Newport Beach
Investigational Site, Anaheim
Investigational Site, Portland
Investigational Site, Edmonton
Investigational Site, Kelowna
Investigational Site, Hamilton
Investigational Site, Ottawa
Investigational Site, Toronto
Investigational Site, Montreal
Investigational Site, Sherbrooke
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY